Cargando…

Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC), and Crohn’s disease (CD), are a group of disorders characterized by chronic, relapsing, and remitting, or progressive inflammation along the gastrointestinal tract. IBD is accompanied by massive infiltration of circulating leuk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luzentales-Simpson, Matthew, Pang, Yvonne C. F., Zhang, Ada, Sousa, James A., Sly, Laura M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887288/ https://www.ncbi.nlm.nih.gov/pubmed/33614645 http://dx.doi.org/10.3389/fcell.2021.612830

Ejemplares similares

A Dietary Cholesterol-Based Intestinal Inflammation Assay for Improving Drug-Discovery on Inflammatory Bowel Diseases
por: Silva, Nuno-Valério, et al.
Publicado: (2021)

Mitochondrial dysfunction in inflammatory bowel disease
por: Novak, Elizabeth A., et al.
Publicado: (2015)

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
por: d’Aldebert, Emilie, et al.
Publicado: (2020)

Identify Inflammatory Bowel Disease-Related Genes Based on Machine Learning
por: Ye, Lili, et al.
Publicado: (2021)

The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease
por: Ma, Shengjie, et al.
Publicado: (2022)

Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
por: Neys, Stefan F. H., et al.
Publicado: (2021)

A Broad m6A Modification Landscape in Inflammatory Bowel Disease
por: Nie, Kai, et al.
Publicado: (2022)

Trichinella spiralis Paramyosin Induces Colonic Regulatory T Cells to Mitigate Inflammatory Bowel Disease
por: Hao, Chunyue, et al.
Publicado: (2021)

Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs
por: Xie, Yufei, et al.
Publicado: (2021)

Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer
por: Tan, Shawn Ying Xuan, et al.
Publicado: (2022)

The diverse roles of macrophages in metabolic inflammation and its resolution
por: Guha Ray, Aleepta, et al.
Publicado: (2023)

m(6)A Modification Mediates Mucosal Immune Microenvironment and Therapeutic Response in Inflammatory Bowel Disease
por: Chen, Yongyu, et al.
Publicado: (2021)

Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition
por: Macias-Ceja, Dulce C., et al.
Publicado: (2023)

Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data
por: Pratt, Molly, et al.
Publicado: (2021)

Know your neighbors: microbial recognition at the intestinal barrier and its implications for gut homeostasis and inflammatory bowel disease
por: Iyer, Krishna, et al.
Publicado: (2023)

The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases
por: Fan, Zhou, et al.
Publicado: (2021)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Skeletal muscle oxidative stress and inflammation in aging: Focus on antioxidant and anti-inflammatory therapy
por: Chen, Mingming, et al.
Publicado: (2022)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Effect of obesity on vedolizumab response in inflammatory bowel disease
por: Levine, Louis J., et al.
Publicado: (2022)

Reducing Inflammation and Vascular Invasion in Intervertebral Disc Degeneration via Cystathionine-γ-Lyase Inhibitory Effect on E-Selectin
por: Xu, Haoran, et al.
Publicado: (2021)

Acid Ceramidase Protects Against Hepatic Ischemia/Reperfusion Injury by Modulating Sphingolipid Metabolism and Reducing Inflammation and Oxidative Stress
por: Jiang, Yuan, et al.
Publicado: (2021)

Communication Between Autophagy and Insulin Action: At the Crux of Insulin Action-Insulin Resistance?
por: Frendo-Cumbo, Scott, et al.
Publicado: (2021)

Estradiol Inhibits ER Stress-Induced Apoptosis in Chondrocytes and Contributes to a Reduced Osteoarthritic Cartilage Degeneration in Female Mice
por: Dreier, Rita, et al.
Publicado: (2022)

Functional and Pathological Roles of AHCY
por: Vizán, Pedro, et al.
Publicado: (2021)

Cathepsin K: The Action in and Beyond Bone
por: Dai, Rongchen, et al.
Publicado: (2020)

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021)

The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases
por: Wu, Xue, et al.
Publicado: (2021)

YAP at the progression of inflammation
por: Chen, Libin, et al.
Publicado: (2023)

Gastric Stem Cells: Physiological and Pathological Perspectives
por: Xiao, Shiyu, et al.
Publicado: (2020)

Editorial: Golgi Dynamics in Physiological and Pathological Conditions
por: Prydz, Kristian, et al.
Publicado: (2020)

Effects of Environmental and Pathological Hypoxia on Male Fertility
por: Li, Zhibin, et al.
Publicado: (2021)

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions
por: Fader Kaiser, Claudio M., et al.
Publicado: (2022)

The Pathology Lesion Patterns of Podocytopathies: How and why?
por: Ravaglia, Fiammetta, et al.
Publicado: (2022)

Editorial: MSC Communication in Physiological and Pathological Settings
por: Bourin, Philippe, et al.
Publicado: (2022)

Editorial: Cellular heterogeneity in physiological and pathological myogenesis
por: Dentice, Monica, et al.
Publicado: (2023)

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab
por: Krupka, Niklas, et al.
Publicado: (2014)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases
por: Shim, Hang Hock, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m7odthgemjbn85tp7d964p44eh